Solution Group Berhad (KLSE:SOLUTN)
Malaysia · Delayed Price · Currency is MYR 0.0750
+0.0050 (7.14%)
At close: Sep 2, 2026
Solution Group Berhad Financials Overview
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 30.7 | 28.67 | 114.97 | 120.93 | 33.2 | 304.61 |
Revenue Growth | -40.15% | -75.06% | -4.92% | 264.21% | -89.10% | 1582.71% |
Gross Profit Gross Profit Growth | 8.44 | 4.57 | 4.53 | 15.15 | -24.73 | 62.11 |
Operating Income Operating Income Growth | -1.3 | -5.4 | -6.51 | 4.75 | -39.17 | 47.14 |
Net Income Net Income Growth | -15.03 | -18.36 | -6.71 | 0.16 | -39.73 | 32.05 |
Earnings Per Share EPS Growth | -0.03 | -0.04 | -0.01 | 0.00 | -0.09 | 0.08 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Eliminations Eliminations Growth | -5.73 | -5.16 | -4.4 | -2.68 | -2.2 | -20.02 |
Engineering Equipment (Excluding Industrial Fabrication and Assembly) Engineering Equipment (Excluding Industrial Fabrication and Assembly) Growth | 16.28 | 13.82 | 10.79 | 6.85 | 5.47 | - |
Metal Fabrication and Assembly Work Metal Fabrication and Assembly Work Growth | 6.77 | 6.09 | 7.19 | 4.89 | 2.44 | 2.45 |
Industrial Automation and Plant Construction Industrial Automation and Plant Construction Growth | 4.73 | 6.82 | 89.97 | 104.27 | 17.28 | 6.08 |
Others Others Growth | 4.24 | 4.06 | 4.98 | 3.39 | 1.96 | 1.46 |
Green and Renewal Energy Green and Renewal Energy Growth | 1.32 | 2.21 | 4.88 | 3.11 | 7.99 | 15.79 |
Biopharmaceuticals & Biotechnology Biopharmaceuticals & Biotechnology Growth | 3.08 | 0.84 | 0.87 | 0.76 | 0.26 | 275.35 |
Investment Investment Growth | - | - | 0.7 | 0.35 | - | 16.25 |
Total Total Growth | 30.7 | 28.67 | 114.97 | 120.93 | 33.2 | 304.61 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 11.27 | 1.97 | 1.69 | 14.63 | 6.6 | 47.65 |
Total Debt Total Debt Growth | 5.22 | 5.27 | 5.79 | 9.2 | 7.18 | 7.66 |
Net Cash (Debt) Net Cash Growth | 6.04 | -3.3 | -4.1 | 5.43 | -0.58 | 39.99 |
Net Cash Growth | - | - | - | - | - | 12.48% |
Net Cash Per Share Net Cash Per Share Growth | 0.01 | -0.01 | -0.01 | 0.01 | -0.00 | 0.10 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 3.84 | 0.09 | -10.46 | -1.63 | -28.85 | 10.62 |
Capital Expenditures CapEx Growth | -0.26 | -0.07 | -0.1 | -0.08 | -0.77 | -18.39 |
Free Cash Flow Free Cash Flow Growth | 3.59 | 0.02 | -10.56 | -1.71 | -29.63 | -7.77 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 27.51% | 15.94% | 3.94% | 12.53% | -74.50% | 20.39% |
Operating Margin | -4.22% | -18.83% | -5.66% | 3.93% | -117.98% | 15.47% |
Pretax Margin | -68.15% | -87.27% | -6.19% | 4.18% | -116.19% | 14.72% |
Profit Margin | -48.95% | -64.02% | -5.83% | 0.14% | -119.65% | 10.52% |
FCF Margin | 11.68% | 0.08% | -9.19% | -1.42% | -89.23% | -2.55% |
| Fiscal Year | FY 2021 |
|---|---|
| Period Ending | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.020 |
Dividend Per Share Growth | - |
Dividend Yield | 3.80% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 649.31 | - | 7.54 |
P/FCF Ratio | 10.12 | 1523.88 | - | - | - | - |
PS Ratio | 1.18 | 1.27 | 0.57 | 0.88 | 4.04 | 0.79 |